Volume 19 Issue 2
Feb.  2021
Turn off MathJax
Article Contents
WU Xu-jie, ZHAO Na, WANG Yi-ru, ZHU Zheng-yu. Clinical curative effect of Shugan Xiehuo Decoction in treating Qiyu Huahuo type post-stroke depression[J]. Chinese Journal of General Practice, 2021, 19(2): 302-304. doi: 10.16766/j.cnki.issn.1674-4152.001794
Citation: WU Xu-jie, ZHAO Na, WANG Yi-ru, ZHU Zheng-yu. Clinical curative effect of Shugan Xiehuo Decoction in treating Qiyu Huahuo type post-stroke depression[J]. Chinese Journal of General Practice, 2021, 19(2): 302-304. doi: 10.16766/j.cnki.issn.1674-4152.001794

Clinical curative effect of Shugan Xiehuo Decoction in treating Qiyu Huahuo type post-stroke depression

doi: 10.16766/j.cnki.issn.1674-4152.001794
Funds:

 2017ZB087

  • Received Date: 2020-07-03
    Available Online: 2022-02-19
  •   Objective  To explore the clinical efficacy of Shugan Xiehuo Decoction in treating Type of stagnated qi turning to fire post-stroke depression (PSD).  Methods  A total of 120 patients with Type of stagnated qi turning to fire PSD treated in Wenzhou Hospital of Traditional Chinese Medicine of Zhejiang University from August 2017 to December 2019 were included in this study. According to the random-number table method, the observation and control groups had 60 patients each. Patients in the control group were treated with sertraline hydrochloride tablets, whereas patients in the observation group were treated with Shugan Xiehuo Decoction for 6 weeks. Patients in the two groups were followed-up, and their HAMD score, NIHSS score, Barthel Index score, and TCM syndrome score were observed. The occurrence of adverse reactions during treatment was compared and analysed.  Results  (1) No statistically significant difference in HAMD score, NIHSS score, Barthel index score, and TCM syndrome score was observed between the two groups before treatment (all P>0.05). Improvement was observed after treatment, and this improvement was significantly higher in the observation group than in the control group (tHAMD score=-2.467, P=0.015; tNIHSS score=-5.707, P < 0.001; tBarthel index score=36.258, P < 0.001; tTCM syndrome score=-7.267, P < 0.001). (2) The incidence of adverse reactions was 8.33% in the observation group and 10.00% in the control group, with no significant difference between both groups (χ2=0.100, P=0.752).  Conclusion  Shugan Xiehuo Decoction has a definite effect on the treatment of Type of stagnated qi turning to fire PSD. On the basis of improving patients' depressive symptoms, it has a certain effect on their neurological rehabilitation and further improves patients' quality of life. No serious adverse drug reactions or drug addiction is observed during treatment.

     

  • loading
  • [1]
    熊飞, 宋沛然. 丹栀逍遥散加减治疗焦虑症的临床效果观察[J]. 中国合理用药探索, 2019, 16(1): 16-19. doi: 10.3969/j.issn.2096-3327.2019.01.005
    [2]
    张玲霞, 唐雪, 王颜佶, 等. 中年脑卒中患者焦虑和抑郁特点及相关因素分析[J]. 中国健康教育, 2019, 35(12): 1130-1133. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGJK201912019.htm
    [3]
    祝善尧, 葛伟, 张欢, 等. 老年急性缺血性脑卒中后抑郁患者睡眠障碍现状及与血清IL-1、IL-2、5-HT和Hypocretin的相关性[J]. 中国老年学杂志, 2020, 40(3): 475-480. doi: 10.3969/j.issn.1005-9202.2020.03.009
    [4]
    刁红梅, 许海东, 张玉敏, 等. 氟哌噻吨美利曲辛片联合盐酸帕罗西汀治疗老年脑卒中后抑郁的效果[J]. 中国老年学杂志, 2020, 40(8): 1677-1679. doi: 10.3969/j.issn.1005-9202.2020.08.033
    [5]
    王恒敏, 严小宏, 田蕾. 艾司西酞普兰联合氯吡格雷对老年脑卒中后抑郁患者的临床疗效和安全性[J]. 中国老年学杂志, 2020, 40(8): 1683-1685. doi: 10.3969/j.issn.1005-9202.2020.08.035
    [6]
    韩振翔, 刘爱华, 侯臻臻, 等. 醒神解郁汤调控BDNF-Th1/Th2改善脑卒中后中重度抑郁患者认知功能及生活质量[J]. 时珍国医国药, 2020, 31(1): 54-56. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY202001017.htm
    [7]
    罗奕. 阿戈美拉汀在缺血性脑卒中后抑郁中的应用[J]. 中国医院药学杂志, 2020, 40(12): 1-5. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYZ202012018.htm
    [8]
    张惜燕, 邢玉瑞. 论中风病因病机理论及其层级划分[J]. 山东中医杂志, 2019, 38(5): 418-421. https://www.cnki.com.cn/Article/CJFDTOTAL-SDZY201905005.htm
    [9]
    钟迪, 张舒婷, 吴波. 《中国急性缺血性脑卒中诊治指南2018》解读[J]. 中国现代神经疾病杂志, 2019, 19(11): 897-901. doi: 10.3969/j.issn.1672-6731.2019.11.015
    [10]
    方红薇, 张秋实, 林玎, 等. 抑郁情绪与老年原发性高血压患者不同时间点血压的相关性研究[J]. 中华全科医学, 2020, 18(7): 1139-1142. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202007022.htm
    [11]
    吕明, 王乙, 吕艳明, 等. 疏肝泻火镇静安神推拿法治疗失眠肝郁化火型[J]. 长春中医药大学学报, 2016, 32(5): 1001, 1053. https://www.cnki.com.cn/Article/CJFDTOTAL-CZXX201605042.htm
    [12]
    郦铮铮, 丛文杰, 郑晓露, 等. 脑卒中后抑郁患者交感神经皮肤反应与血浆多巴胺、5-羟色胺及HAMD评分的相关性分析[J]. 中华全科医学, 2019, 17(3): 384-387. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201903013.htm
    [13]
    甄莉丽, 彭光海, 邹晓君, 等. 舒肝解郁胶囊对脑卒中后抑郁的疗效及改善日常生活能力的meta分析[J]. 中国老年学杂志, 2018, 38(16): 3959-3963. doi: 10.3969/j.issn.1005-9202.2018.16.049
    [14]
    田姗姗, 郭海飞. 乌灵胶囊联合抗抑郁药物治疗脑卒中后抑郁的综合评价[J]. 中风与神经疾病杂志, 2017, 34(5): 443-445. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFSJ201705013.htm
    [15]
    宋炜熙, 仲美琼, 唐燕萍, 等. 脑卒中后抑郁不同中医证型情绪测量分析[J]. 中华中医药学刊, 2016, 34(10): 2435-2437. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201610036.htm
    [16]
    刘德芳, 邓燕春, 梁汝沛, 等. 养血清脑饮协定方联合盐酸帕罗西汀片治疗老年脑卒中后抑郁的临床效果及对血清5-HT、IL-1、Hcy水平的影响[J]. 陕西中医, 2018, 39(1): 47-49. https://www.cnki.com.cn/Article/CJFDTOTAL-SXZY201801015.htm
    [17]
    BACKHOUSE E V, MC HUTCHISON C A, CVORO V, et al. Cognitive ability, education and socioeconomic status in childhood and risk of post-stroke depression in later life: a systematic review and meta-analysis[J]. PLoS One, 2018, 13(7): 525. http://europepmc.org/articles/PMC6047794/
    [18]
    孙文哲, 朱舟, 朱遂强. 卒中后抑郁研究新进展[J]. 神经损伤与功能重建, 2018, 13(11): 558-561. https://www.cnki.com.cn/Article/CJFDTOTAL-GWKF201811006.htm
    [19]
    江利敏, 刘向哲. 丹栀逍遥散加减治疗卒中后抑郁的疗效及作用机制[J]. 中国实验方剂学杂志, 2019, 25(3): 108-113. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201903017.htm
    [20]
    官梦梅, 李义. 脑卒中后认知功能障碍的研究进展[J]. 齐齐哈尔医学院学报, 2018, 39(24): 2947-2950. https://www.cnki.com.cn/Article/CJFDTOTAL-QQHB201824039.htm
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Article Metrics

    Article views (278) PDF downloads(0) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return